{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:49:21Z","timestamp":1782103761498,"version":"3.54.5"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018987","name":"Ministerul Cercet\u0103rii, Inov\u0103rii \u015fi Digitaliz\u0103rii","doi-asserted-by":"publisher","award":["PN-III-P4-PCE-2021-1344 , PN-IV-PRO-CoEx-2024-1"],"award-info":[{"award-number":["PN-III-P4-PCE-2021-1344 , PN-IV-PRO-CoEx-2024-1"]}],"id":[{"id":"10.13039\/100018987","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic foot syndrome (DFS) is characterized by chronic inflammation, thrombotic imbalance, and impaired wound healing, yet systemic molecular alterations underlying this complication remain incompletely defined. In this study, we combined clinical plasma proteomics with experimental pharmacological modulation to characterize a circulating damage-associated molecular pattern (DAMP)-related signature linked to systemic inflammatory signaling in DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma samples from patients with type 2 diabetes with and without DFS, including individuals with varying degrees of limb ischemia, were analyzed using liquid chromatography-tandem mass spectrometry. Differentially abundant proteins were evaluated in relation to inflammatory, hematological, and metabolic parameters. Pharmacological responsiveness was assessed in a murine diabetic ischemic wound model treated with a selective Toll-like receptor 4 (TLR4) inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Proteomic analysis identified coordinated differences in the abundance of multiple acute-phase and stress-associated proteins, including serum amyloid A1, serum amyloid A2, serum amyloid P component, S100A8, defensin alpha 1B, fibrinogen chains, heat shock protein family A member 5, thymosin beta 4, fibronectin 1, and tenascins. These proteins exhibited differences between DFS patients and diabetic controls and were explored in relation to systemic inflammatory variables. Several DAMPs demonstrated reproducible patterns across the studied groups, suggesting the presence of a coordinated circulating molecular pattern rather than isolated changes in individual proteins. In diabetic ischemic mice, TLR4 inhibition was associated with altered abundance of several circulating proteins, including reductions in selected amyloid-associated proteins. These observations suggest an association between modulation of innate immune signaling pathways and circulating protein profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, these findings support a systemic alteration in circulating DAMP abundance in DFS and provide exploratory clinical and experimental evidence to guide future investigations into DAMP-mediated inflammatory pathways in diabetic ischemic complications. Proteomics data are available via ProteomeXchange with identifier PXD073507.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1849387","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:25Z","timestamp":1782102865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Elena","family":"Uyy","sequence":"first","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel-Iulian","family":"Suica","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Ivan","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca Maria","family":"Boteanu","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Valentina","family":"Uta","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Georgiana","family":"Bernea","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drago\u015f Eugen","family":"Georgescu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cDr. Ion Cantacuzino\u201d Clinical Hospital","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chiriac","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cDr. Ion Cantacuzino\u201d Clinical Hospital","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Simionescu","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Antohe","sequence":"additional","affiliation":[{"name":"Proteomics Department, Institute of Cellular Biology and Pathology \u201cNicolae Simionescu\u201d, of Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S146484","article-title":"Lower-extremity amputations in people with and without diabetes in Germany, 2008\u20132012 \u2013 an analysis of more than 30 million inhabitants","volume":"10","author":"Claessen","year":"2018","journal-title":"Clin Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082155","article-title":"Therapeutic alternatives in diabetic foot patients without an option for revascularization: A narrative review","volume":"11","author":"R\u00fcmenapf","year":"2022","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3273","article-title":"Guidelines on the classification of diabetic foot ulcers (IWGDF 2019)","volume":"36","author":"Monteiro-Soares","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1086\/424846","article-title":"Diagnosis and treatment of diabetic foot infections","volume":"39","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.464","article-title":"Diabetic foot ulcer classification system for research purposes: A progress report on criteria for including patients in research studies","volume":"20","author":"Schaper","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3237","article-title":"State of the art design protocol for custom made footwear for people with diabetes and peripheral neuropathy","volume":"36","author":"Bus","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30438-2","article-title":"Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): An international, multicentre, double-blind, randomised, controlled trial","volume":"6","author":"Edmonds","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30240-7","article-title":"LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: An observer-masked, randomised controlled trial","volume":"6","author":"Game","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12329","article-title":"The efficacy and safety of Grafix\u00ae for the treatment of chronic diabetic foot ulcers: Results of a multicentre, controlled, randomised, blinded, clinical trial","volume":"11","author":"Lavery","year":"2014","journal-title":"Int Wound J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/918267","article-title":"Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing","volume":"2012","author":"Kolluru","year":"2012","journal-title":"Int J Vasc Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/24730114231193418","article-title":"The evaluation and treatment of diabetic foot ulcers and diabetic foot infections","volume":"8","author":"Del Core","year":"2023","journal-title":"Foot Ankle Orthop"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314774","article-title":"Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: A systematic review and meta-analysis","volume":"40","author":"Kremers","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2017.05.009","article-title":"Systematic review and meta-analysis of the association between C-reactive protein and major cardiovascular events in patients with peripheral artery disease","volume":"54","author":"Singh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.263798","article-title":"Biomarkers and genetics in peripheral artery disease","volume":"63","author":"Hazarika","year":"2017","journal-title":"Clin Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073601","article-title":"The role of circulating biomarkers in peripheral arterial disease","volume":"22","author":"Saenz-Pipaon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2016.11.006","article-title":"Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer","volume":"153","author":"Boteanu","year":"2017","journal-title":"J Proteomics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1799","article-title":"Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41598-022-06762-y","article-title":"Regulated cell death joins in atherosclerotic plaque silent progression","volume":"12","author":"Uyy","year":"2022","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00146","article-title":"Novel aspects of fibrin(ogen) fragments during inflammation","volume":"17","author":"Jennewein","year":"2011","journal-title":"Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: Sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflammation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2001.280.5.L947","article-title":"Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion","volume":"280","author":"Zhang","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111793","article-title":"The circulating GRP78\/BiP is a marker of metabolic diseases and atherosclerosis: Bringing endoplasmic reticulum stress into the clinical scenario","volume":"8","author":"Girona","year":"2019","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.12.012","article-title":"The regulation of tenascin expression by tissue microenvironments","volume":"1793","author":"Tucker","year":"2009","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.318237","article-title":"Extracellular matrix remodeling in vascular disease: Defining its regulators and pathological influence","volume":"43","author":"Lin","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4161\/19336918.2014.994893","article-title":"Tenascin-X: Beyond the architectural function","volume":"9","author":"Valcourt","year":"2015","journal-title":"Cell Adhes Migr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1369\/0022155417740880","article-title":"Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity","volume":"66","author":"Frevert","year":"2018","journal-title":"J Histochem Cytochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.O115.050229","article-title":"PRIDE Inspector Toolsuite: Moving towards a universal visualization tool for proteomics data standard formats and quality assessment of ProteomeXchange datasets","volume":"15","author":"Perez-Riverol","year":"2016","journal-title":"Mol Cell Proteomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:29Z","timestamp":1782102869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1849387"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1849387","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1849387"}}